Prognostic models in myelodysplastic syndromes

被引：2
|
作者：
Della Porta, Matteo Giovanni [1 ,2 ]
机构：
[1] Fdn Ist Ricovero Cura & Carattere Sci IRCCS Polic, Dept Hematol Oncol, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 06期
关键词：
SCORING SYSTEM; MUTATIONS;
D O I：
10.1016/S2352-3026(15)00110-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E229 / E230
页数：2
相关论文
共 50 条
  • [1] Prognostic models in myelodysplastic syndromes
    Bejar, Rafael
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 504 - 510
  • [2] Novel Prognostic Models for Myelodysplastic Syndromes
    Shreve, Jacob
    Nazha, Aziz
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (02) : 369 - +
  • [3] The Search for Better Prognostic Models in Myelodysplastic Syndromes
    Santos, Fabio P. S.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (01) : 13 - 21
  • [4] Prognostic Markers of Myelodysplastic Syndromes
    Veryaskina, Yuliya Andreevna
    Titov, Sergei Evgenievich
    Kovynev, Igor Borisovich
    Pospelova, Tatiana Ivanovna
    Zhimulev, Igor Fyodorovich
    MEDICINA-LITHUANIA, 2020, 56 (08): : 1 - 16
  • [5] Improving Prognostic Modeling in Myelodysplastic Syndromes
    Nazha, Aziz
    Sekeres, Mikkael A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) : 395 - 401
  • [6] (In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes
    Calvo, Xavier
    Florensa, Lourdes
    Arenillas, Leonor
    LEUKEMIA, 2018, 32 (05) : 1264 - 1266
  • [7] Improving Prognostic Tools for Patients With Myelodysplastic Syndromes
    Garcia-Manero, Guillermo
    MAYO CLINIC PROCEEDINGS, 2018, 93 (10) : 1340 - 1342
  • [8] Classification and Prognostic Evaluation of Myelodysplastic Syndromes
    Cazzola, Mario
    Della Porta, Matteo G.
    Travaglino, Erica
    Malcovati, Luca
    SEMINARS IN ONCOLOGY, 2011, 38 (05) : 627 - 634
  • [9] Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
    Nazha, A.
    Al-Issa, K.
    Hamilton, B. K.
    Radivoyevitch, T.
    Gerds, A. T.
    Mukherjee, S.
    Adema, V.
    Zarzour, A.
    Abuhadra, N.
    Patel, B. J.
    Hirsch, C. M.
    Advani, A.
    Przychodzen, B.
    Carraway, H. E.
    Maciejewski, J. P.
    Sekeres, M. A.
    LEUKEMIA, 2017, 31 (12) : 2848 - 2850
  • [10] Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure
    Patel, Sagar S.
    Sekeres, Mikkael A.
    Nazha, Aziz
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2532 - 2539
12345